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An update on virology and emerging viral epidemics 
Introduction 
 
A virus is a small infectious agent that is able to repli-
cate only inside the living cells of an organism, known 
as a host. Viruses can infect all types of organisms, 
from animals and plants to bacteria and archaea 
(Koonin et al. 2006). They have been characterized as 
obligate intracellular parasites since they lack the 
metabolic enzymes and equipment for making proteins 
(Reece et al. 2010). In other words, they can reproduce 
and carry out metabolic activities only within a host 
cell. Hence, lacking these basic mechanisms, most vi-
ruses are little more than genetic material contained in 
protein coats (Crawford 2011). 
 It is often debated whether a virus should be 
considered a living organism or a non-living chemical 
system. Some biologists claim that they are not "alive" 
but exist in a shady area between life-forms and 
chemicals. As a matter of fact, the Latin root for the 
word virus means “poison”. A simple phrase used re-
cently by two researchers describes them aptly enough: 
Viruses lead “a kind of borrowed life” (Villarreal 
2004). A virus will remain dormant until it is able to 
infect the next host, activate and replicate. Some vi-
ruses can live in an open place for a short time, in 
some cases, only a few hours. Viruses use the most 
efficient methods to locate a host, create copies, and 
spread to other hosts (Dimmock et al. 2007). 
 They are considered to be formidable patho-
gens of animals and plants. The damage that they can 
cause depends on the type of the virus and the host 
cells. In some cases, they can damage or kill cells by 
inflicting the release of hydrolytic enzymes from ly-
sosomes. In addition, some viruses cause host cells to 
produce toxins that lead to disease states, and others 
have molecular components that are toxic, such as en-
velope proteins. How much damage a virus causes de-
pends partly on the ability of the infected tissue to re-
generate by cell division. For instance, damage in-
flicted by poliovirus to mature nerve cells is perma-
nent, since these cells cannot normally be replaced. It 
should be clarified that many of the temporary symp-
toms associated with viral infections, such as fever and 
aches, result from the response of the immune system 
itself rather than from cell death caused by the virus 
(Reece et al. 2010). 
 Obviously, beyond their pathogenic role, vi-
ruses have experimental and research value. Molecular 
biology, biotechnology and a variety of medical appli-
cations were born in the laboratories of biologists 
studying viruses that infect bacteria. Their value as 
experimental systems contributed to a better under-
standing of the fundamental processes of DNA replica-
tion, transcription, and translation and provided evi-
dence that genes are made of nucleic acids (Vlachakis 
2009). Moreover, they led to the development of tech-
niques related to gene manipulation i.e. in gene ther-
apy viruses are used as agents of gene transfer.  
 
The Discovery of Viruses: Scientific Inquiry 
 
Scientists discovered viruses in the late 1800s by 
studying a plant disease; tobacco mosaic, which stunts 
the growth of tobacco plants and gives their leaves mo-
saic coloration. In fact, researchers were able to detect 
viruses indirectly long before they were actually able 
to see them. In 1883, Adolf Mayer, a German scientist, 
discovered that the disease could be transmitted from 
plant to plant by simply rubbing sap extracted from 
diseased leaves onto healthy ones (Mayer 1886). How-
ever, Mayer was not able to determine the infectious 
microbe. He just suggested that the disease was caused 
by unusually small bacteria that were invisible under a 
microscope. 
 In 1892, this hypothesis was tested by Dimitri 
lvanowsky, a Russian biologist who gave the first con-
crete evidence for the existence of a non-bacterial in-
fectious agent. Specifically, he designed a filter to re-
move bacteria, known as Chamberland filter candles. 
He passed sap from infected tobacco leaves through it 
and showed that the sap still produced mosaic disease 
(Iwanowski 1903). But Ivanowsky remained rather 
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convinced that the causal agent was an unculturable 
bacterium. He reasoned the bacteria were too small to 
be retained on the employed filter or made a toxin that 
could do so. The Dutch botanist Martinus Beijerinck 
carried out experiments that ruled out the second pos-
sibility, showing that the infectious agent in the filtered 
sap was able to reproduce and multiply in the host 
cells of the tobacco plant (Beijerinck 1898).  
 Beijerinck is generally credited with being the 
first scientist to voice the concept of a virus. After a 
series of other experiments, he showed that the myste-
rious agent of mosaic disease could not be cultivated 
on nutrient media in test tubes or petri dishes, unlike 
bacteria used in the lab at the time. Beijerinck imag-
ined a reproducing particle much smaller and simpler 
than a bacterium. Hence, he coined the term "virus" to 
indicate that the causal agent of tobacco mosaic dis-
ease was of non-bacterial nature.  
 In 1935, the American scientist Wendell 
Stanley crystallized the infectious particle, now known 
as tobacco mosaic virus (TMV), confirming Beijer-
inck’s suspicions. In addition, he showed that this vi-
rus remains active even after crystallization 
(Iwanowski 1903). TMV was the first virus to be crys-
tallized. Subsequently, TMV and many other viruses 
were actually seen with the help of the electron micro-
scope (Kausche et al. 1939). The investigations of to-
bacco mosaic disease and discovery of its viral nature 
were fundamental in the establishment of the basic 
concepts of virology. 
 
Structure, Lifecycle and Evolution 
 
Examining the structure of viruses more closely re-
veals that the nucleic acid of a virion (the entire infec-
tious virus particle outside the cell) is enclosed within 
a protein capsid and sometimes a membranous enve-
lope composed of viral proteins that helps the virus 
enter the cell. In fact, the tiniest viruses are only 20 nm 
in diameter and millions could easily fit on a pinhead. 
 
Viral Genomes 
Viral genomes may consist of double or single 
stranded DNA (ds- or ssDNA), double or single 
stranded RNA (ds- or ssRNA); this depends on the 
type of virus. The term "DNA" or "RNA" virus is 
based on the kind of nucleic acid that makes up its ge-
nome. In addition, the genome is usually organized as 
a single linear or circular molecule of nucleic acid, 
although the genomes of some viruses consist of multi-
ple molecules of nucleic acid (e.g. influenza virus).  
 
Capsids and Envelopes 
The capsid is the protein shell that encloses the viral 
genome. Capsids are composed of a large number of 
protein subunits called capsomeres, but the number of 
different kinds of proteins in a capsid is usually small. 
Capsomeres are closely associated with the nucleic 
acid and reflect its configuration; either a rod-shaped 
helix or a polygon-shaped sphere (Lidmar et al. 2003). 
Some viruses, such as bacteriophages (viruses that in-
fect and replicate within bacteria), have developed 
more complex structures due to constraints of electro-
statics and elasticity (Vernizzi et al. 2011).  
 The capsid performs three main functions. 
Firstly, it has a protective role as it prevents the nucleic 
acid from being digested by enzymes. Secondly, it al-
lows the virion to attach to a host cell through its spe-
cial sites on its surface. Finally, some proteins of the 
capsid enable the virion to penetrate the host cell mem-
brane and inject the infectious nucleic acid into the 
cell’s cytoplasm. 
 For instance, the tobacco mosaic virus has a 
helical capsid since it is made from over a thousand 
molecules of a single type of protein arranged in a he-
lix with the overall shape of a rigid rod (Branden & 
Tooze 1991). Furthermore, adenoviruses, which infect 
the respiratory tracts of animals, have a capsid that is 
composed of 252 identical proteins organized in a 
polyhedral shape, with 20 triangular facets -an icosahe-
dron; thus, these and other similarly shaped viruses are 
referred to as icosahedral viruses (Caspar & Klug 
1962).  
 Some viruses have a membranous envelope 
that surrounds their capsids. The envelope functions as 
an accessory structure that helps them infect their 
hosts. It is composed of two lipid layers interspersed 
with protein molecules (lipoprotein bilayer). Viral en-
velopes, which are derived from the membrane of the 
host cell, may contain its membrane proteins and phos-
pholipids. The virus obtains the lipid molecules from 
the cell membrane during the viral budding process. 
They also contain materials (proteins and glycopro-
teins) of viral origin. It is worth noting that sometimes 
the virus creates a hybrid structure of cell-derived lip-
ids and virus-derived proteins, replacing the proteins in 
the cell membrane with its own proteins. Additionally, 
many viruses develop spikes made of glycoproteins on 
their envelopes that contribute to viral binding. 
 
General Features of Viral Reproductive Cycles 
The term "host range of a virus" represents the variety 
of hosts that each type of virus can infect and it is, in 
fact, actually limited. Due to the evolution of viral rec-
ognition systems, a virus is able to identify host cells 
by a "lock-and-key" fit between viral surface proteins 
and specific receptor molecules on the membrane of 
the host cells. A viral infection begins when a virus 
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binds to a host cell and the viral genome makes its way 
inside. The viral entry is dependent on the host cell and 
the type of the virus. It can occur via three processes; 
membrane fusion, endocytosis and genetic injection. In 
the first case, the viral receptors attach to the receptors 
on the surface of the host cell and, thereafter, receptors 
may initiate the puncture of the cell membrane or fu-
sion with the host cell (Campadelli-Fiume et al. 2007). 
During entry via endocytosis, the virus "tricks" the cell 
into thinking that the virus knocking at the door is 
nothing more than nutrients or "harmless 
goods" (Dimmock et al. 2007). Finally, in the case of 
genetic injection, the virus only injects its genome into 
the host cell after attaching to its surface. An example 
of the latter includes the phage viruses (Sebestyén et 
al. 2006). 
 Once the viral genome is inside, the proteins it 
encodes reprogram the cell to translate the viral ge-
nome and transcript viral proteins. The host provides 
the nucleotides for creating viral nucleic acids, as well 
as enzymes, ribosomes, tRNAs, ATPs, amino acids, 
and other components necessary for making viral pro-
teins. The DNA polymerase of the host cell is used in 
order to replicate the genome of the DNA virus. In 
contrast, RNA viruses use their own RNA polymerase, 
encoded by its viral genes. Recent studies have em-
ployed bioinformatics techniques to study the diverse 
viral enzymes (Sellis et al. 2009, 2012, Vlachakis et al. 
2013a, b). 
 Consequently, the viral nucleic acid molecules 
and capsomeres self-assemble into new viruses. The 
cell is now no longer useful to the virus; therefore it 
must find a new host. Hence, the simplest type of viral 
reproductive cycle ends with the exit of hundreds or 
thousands of viruses from the infected host cell, a 
process that is called shedding and often damages or 
destroys the cell. Such cellular damage and death, as 
well as the body's responses to this destruction, cause 
many of the symptoms associated with viral infections. 
The viral progeny that exit a cell have the potential to 
infect additional cells, spreading the viral infection 
(Reece et al. 2010). 
 It is worth noting that some viruses have the 
potential to "hide" inside the host cell, either to defend 
itself against the host cell defenses or immune system, 
or because the conditions are not appropriate for the 
virus to make more copies. This "hiding" is 
called latency. During this time, the virus will remain 
inactive until an external stimulus prompts it into acti-
vation, or the restart of the life cycle. 
 There are numerous variations of the viral re-
productive cycle. For instance, in the case of phages 
two alternative mechanisms can be described: the lytic 
and the lysogenic cycle. The first one culminates in the 
death of the host cell as it triggers the bacterium lysis 
and the release of the phages. Contrary, the lysogenic 
cycle allows replication of the phage genome without 
destroying the host. The term lysogenic implies that 
prophages have the potential to generate active phages 
that lyse their host cells (Reece et al. 2010). 
 There are a lot of variations concerning the 
mechanisms of viral infection and production of new 
viruses. The nature of the viral genome (DNA/ RNA, 
single-stranded/double-stranded) is a principal vari-
able. The broadest variety of RNA genomes is detected 
among viruses that infect animals, even though most 
plant and some phages viruses are RNA viruses. 
 More specifically, ssRNA viruses are further 
classified into three classes (lV-VI) depending on the 
function of the RNA genome in a host cell. The ge-
nome of class IV viruses can directly serve as mRNA 
and hence be translated immediately after infection.  In 
class V viruses, the RNA serves as a template for RNA 
synthesis. In this way, it is transcribed into comple-
mentary RNA strands (cRNA) which is used both as 
mRNA and as template for the synthesis of additional 
copies of genomic RNA. Finally, the class VI viruses 
are equipped with the reverse transcriptase enzyme, 
thereby transcribing RNA to DNA. Of particular medi-
cal importance is HIV (human immunodeficiency vi-
rus); the well-known retrovirus that causes AIDS 
(acquired immunodeficiency syndrome). 
 
Evolution of viruses 
There is a scientific debate concerning the origins of 
viruses. Since they depend on cells, it seems likely that 
viruses are not the descendants of precellular forms of 
life but evolved after the first cells appeared (Iyer et al. 
2006).  There are three main hypotheses about the ori-
gins of viruses.  According to the regressive hypothe-
sis, viruses may have once been small cells 
that parasitized larger cells (Regenmortel 2010). The 
other is the cellular origin hypothesis, which refers to 
viruses that may have evolved from bits of DNA or 
RNA that "escaped" from the genes of a larger organ-
ism. The escaped DNA could have come 
from plasmids  or transposons. In this regard, plas-
mids, transposons, and viruses all share an important 
feature: they are mobile genetic elements 
(Palaiomylitou et al. 2008, Vlachakis et al. 2013a). 
 
Emerging Viruses 
Newly discovered viruses that increase or have the 
potential to increase in incidence are often referred to 
as emerging viruses. The deadly viruses of AIDS, 
some types of influenza (like the H7N9 strain), Ebola, 
SARS (severe acute respiratory syndrome) and West 
Nile are representative cases of emerging viruses that 
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affect and cause death of millions of people. 
 There are three processes that attempt to ex-
plain how such viruses can burst on the human scene, 
giving rise to harmful diseases that were previously 
rare or even unknown. The first is mutations, which is 
very usual in RNA viruses. RNA viruses tend to have 
higher rates of mutation due to errors in RNA replica-
tion as RNA polymerase lacks proofreading abilities. 
Hence, some mutations lead to new genetic varieties 
(strains) that can cause disease, even in individuals 
who are immune to the ancestral virus. A representa-
tive case is that of general outbreaks of flu, or flu epi-
demics that are caused by new strains of the influenza 
virus. 
 The second factor is associated with the dis-
semination of a viral disease from a small, isolated 
human population. Technological, social and environ-
mental factors could be involved in this case. For ex-
ample, HIV was an unnoticed human disease for dec-
ades before suddenly beginning to spread around the 
world. This event was favored by numerous factors 
including affordable international travel, sexual prom-
iscuity, blood transfusions, and the abuse of intrave-
nous drugs. 
 A third source that leads to the emergence of 
viral diseases is the spread of existing viruses from 
other animals. These animals are said to act as a natu-
ral reservoir for that virus since they harbor and trans-
mit a particular virus but are unaffected by it. It is esti-
mated that about three-quarters of new human diseases 
originate in this way. SARS virus is a classic example: 
a species of bat has been identified as its likely natural 
reservoir. Bats are sold as food in China, and their 
dried feces are even sold for medicinal purposes; either 
of these practices could provide a route for transmis-
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